Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1Psychological Well-Being 1Periampullary Carcinoma Nos 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Esophageal Neoplasms 1Enteritis 1Diarrhea 1Abdominal Pain 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Probiotics × Clear all
NCT01839721 2013-05-17

Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation

CHU de Quebec-Universite Laval

Phase 3 Completed
246 enrolled

Diarrhea, Enteritis, Neoplasms, Abdominal Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡